ALLISON GILROY: Open Payments
NPI 1548807019 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$771 in 41 payments from 14 companies in 2025. Trend: 2023 $177 · 2024 $1,088 · 2025 $771
Food & beverage: $771
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $163 |
| ABBVIE INC. | 8 | $151 |
| PFIZER INC. | 7 | $120 |
| Boston Scientific Corporation | 2 | $46 |
| Astellas Pharma US Inc | 2 | $45 |
| Novo Nordisk Inc | 2 | $37 |
| Eisai Inc. | 2 | $36 |
| Amgen Inc. | 2 | $33 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Inspire Medical Systems, Inc. | 1 | $28 |
Products named: VYNDAQEL, MOUNJARO, QULIPTA, VRAYLAR, JARDIANCE, WATCHMAN Access System, Veozah, Leqembi.
Industry payments across IN — which companies pay providers there.
